| Literature DB >> 32847604 |
Kathrin Lauber1,2, Rob Ralston3, Mélissa Mialon4, Angela Carriedo5, Anna B Gilmore6,7.
Abstract
BACKGROUND: The UN system's shift towards multistakeholder governance, now embedded in the Sustainable Development Goals (SDGs), invites a broad range of actors, including the private sector, to the policymaking table. Although the tobacco industry is formally excluded from engagement, this approach provides opportunities for other unhealthy commodity industries to influence the World Health Organization's (WHO's) non-communicable disease (NCD) agenda. Focusing on the food industry, this research maps which actors engaged with WHO consultations, and critically examines actors' policy and governance preferences as well as the framing they employ to promote these preferences in the global context.Entities:
Keywords: Commercial determinants of health; Corporate political activity; Food industry; Global health governance; Non-communicable diseases
Mesh:
Year: 2020 PMID: 32847604 PMCID: PMC7448499 DOI: 10.1186/s12992-020-00611-1
Source DB: PubMed Journal: Global Health ISSN: 1744-8603 Impact factor: 4.185
Definitions
| | |
| |
Included WHO consultations and a breakdown of total responses showing private sector submissions and the overt food/beverage submissions included within these
| Consultation title | Dates | Details | Total number of responses | Private sector responses | Responses representing food industry |
|---|---|---|---|---|---|
| 10–16 May 2018 | Held following a technical consultation in March 2018 [ | 215 | 47 | 19 | |
| 11–25 August 2017 | Consultation linked to the WHO Global Conference on enhancing policy coherence to prevent and control NCDs in October 2017. Outcome: | 97 | 17 | 8 | |
| 11–29 September 2017 | Consultation on an approach for the prevention and management of COI in the policy development and implementation of nutrition programmes at country level, following a technical consultation [ | 44 | 14 | 12 | |
| 25 July–1 September 2016 | As requested at the 69th WHA, Appendix 3 of the WHO Global NCD Action Plan 2013–2020, a menu of policy options and cost-effective interventions for NCD prevention and control, was updated. This formed the basis of the WHO | 64 | 9 | 4 | |
| 20 May–15 October 2016 | Consultation on a draft considered at the 9th Global Conference on Health Promotion in November 2016 which aimed to position health promotion as fundamental to Sustainable Development. Outcome: | 17 | 4 | 2 | |
Fig. 1Food industry business associations and their membership links to the four largest, multinational ultra-processed food corporations. This figure shows food industry BAs who participated in the included consultations and their links to the four largest packaged food and soft drinks corporations (based on Euromonitor data for packaged food [46] and soft drinks [47]). Dashed lines between companies and BAs indicate an indirect link through a member organisation (* = ‘umbrella’ BA without direct corporate members). † indicates that a company was a member for at least part of the study period (Sept 2015 – Sept 2018) but has since left. More information in Additional file 1. This visualisation was created using PowerPoint [58]
Policy and governance frames and arguments. The ‘NCD interventions’ category refers to arguments about what should be done to tackle NCDs. For simplicity, NCD interventions were grouped into two categories: (a) regulation and (b) self- and co-regulation (SR/CR). The former comprises regulatory interventions such as taxation, marketing restrictions and bans, and mandatory labelling. The latter comprises non-statutory or voluntary initiatives and public-private partnerships to address NCDs. ‘Broader governance’ encompasses issues pertaining to how decisions are made, who governs, and who is governed. This includes, for example, broader questions about the role of industry in policymaking
| Key arguments in the context of: | |||
|---|---|---|---|
| FRAME | |||
| Regulation is too simplistic for the complex issue of NCDs | The complexity of NCDs necessitates collaboration with industry | ||
| Enough regulation is already in place | Conflict of interest is sufficiently managed (through FENSA) | ||
| Industry is already regulating itself | |||
| NCDs can be sufficiently addressed through non-statutory interventions | |||
| Successful past collaboration justifies a partnership approach to NCD policy | Industry is a necessary partner in addressing NCDs | ||
| Industry is a legitimate actor in NCD policy | Food industry is different to tobacco (or alcohol) industry | ||
| Food industry is an important stakeholder | |||
| Risk of engagement does not justify exclusion | |||
| Regulation may not have the intended health benefit (or may be counterproductive) | Restricting industry engagement in policymaking risks undermining the fight against NCDs | ||
| Regulation may have unanticipated negative consequences | |||
| There is insufficient (good) evidence in support of regulation | Industry supports evidence-based policymaking | ||
| The existing evidence does not support regulation | Evidence-based policymaking requires the inclusion of all available evidence (including from industry) | ||
| Good governance requires working with industry | |||
| Achieving policy coherence requires private sector input and alignment of health with economic agendas | |||
| WHO is overstepping its mandate | |||
| Restricting industry engagement is incoherent with the multistakeholder approach (and the SDGs) | |||
| National sovereignty | National governments hold the primary responsibility for addressing NCDs | ||
| Policy may infringe on national sovereignty | |||
| Policy may be incoherent with national legal obligations | |||